New hope for Tough-to-Treat lung cancer?
NCT ID NCT02513563
Summary
This study tested whether adding an experimental drug called AZD1775 to standard chemotherapy (carboplatin and paclitaxel) could help control advanced squamous cell lung cancer. It involved 42 adults whose cancer had spread and had no known curative options. The main goal was to see if this combination could delay cancer progression and was safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.